These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 7381849)
41. In vivo intraneuronal MAO inhibition in rat brain SKF 64139, comparison to other potent PNMT inhibitors. Mefford IN; Roth KA; Gilberg M; Barchas JD Eur J Pharmacol; 1981 Mar; 70(3):345-53. PubMed ID: 7227455 [TBL] [Abstract][Full Text] [Related]
42. Studies on the characterization and inhibition of rat brain phenylethanolamine N-methyltransferase. Pendleton RG; Khalsa J; Gessner G; Sawyer J Naunyn Schmiedebergs Arch Pharmacol; 1977 Oct; 299(3):219-24. PubMed ID: 927550 [TBL] [Abstract][Full Text] [Related]
43. Ihibition of rat brain norepinephrine N-methyltransferase in vitro and in vivo by chloro-substituted 1-aminoindans. Fuller RW; Hemrick SK; Molloy BB; Day WA Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):485-95. PubMed ID: 7384638 [TBL] [Abstract][Full Text] [Related]
44. Blood pressure response to central and/or peripheral inhibition of phenylethanolamine N-methyltransferase in normotensive and hypertensive rats. Black J; Waeber B; Bresnahan MR; Gavras I; Gavras H Circ Res; 1981 Aug; 49(2):518-24. PubMed ID: 7249286 [TBL] [Abstract][Full Text] [Related]
45. Effects of a 3-alkyl-, 4-hydroxy- and/or 8-aromatic-substituent on the phenylethanolamine N-methyltransferase inhibitor potency and alpha2-adrenoceptor affinity of 2,3,4,5-tetrahydro-1H-2-benzazepines. Grunewald GL; Dahanukar VH; Criscione KR Bioorg Med Chem; 2001 Aug; 9(8):1957-65. PubMed ID: 11504632 [TBL] [Abstract][Full Text] [Related]
46. Time-dependent inactivation of human phenylethanolamine N-methyltransferase by 7-isothiocyanatotetrahydroisoquinoline. Wu Q; Caine JM; Thomson SA; Slavica M; Grunewald GL; McLeish MJ Bioorg Med Chem Lett; 2009 Feb; 19(4):1071-4. PubMed ID: 19171483 [TBL] [Abstract][Full Text] [Related]
47. Epinephrine synthesis in the rat iris. Elayan H; Kennedy B; Ziegler MG Invest Ophthalmol Vis Sci; 1990 Apr; 31(4):677-80. PubMed ID: 2335436 [TBL] [Abstract][Full Text] [Related]
48. Exploring the active site of phenylethanolamine N-methyltransferase with 1,2,3,4-tetrahydrobenz[h]isoquinoline inhibitors. Grunewald GL; Seim MR; Regier RC; Criscione KR Bioorg Med Chem; 2007 Feb; 15(3):1298-310. PubMed ID: 17126018 [TBL] [Abstract][Full Text] [Related]
49. Application of the Goldilocks effect to the design of potent and selective inhibitors of phenylethanolamine N-methyltransferase: balancing pKa and steric effects in the optimization of 3-methyl-1,2,3,4-tetrahydroisoquinoline inhibitors by beta-fluorination. Grunewald GL; Seim MR; Lu J; Makboul M; Criscione KR J Med Chem; 2006 May; 49(10):2939-52. PubMed ID: 16686536 [TBL] [Abstract][Full Text] [Related]
50. Norepinephrine N-methyltransferase inhibition by benzamidines, phenylacetamidines, benzylguanidines, and phenylethylguanidines. Fuller RW; Roush BW; Snoddy HD; Day WA; Molloy BB J Med Chem; 1975 Mar; 18(3):304-7. PubMed ID: 1133822 [TBL] [Abstract][Full Text] [Related]
51. Role of central epinephrine on the regulation of corticotropin-releasing factor and adrenocorticotropin secretion. Spinedi E; Johnston CA; Chisari A; Negro-Vilar A Endocrinology; 1988 May; 122(5):1977-83. PubMed ID: 2834181 [TBL] [Abstract][Full Text] [Related]
52. The influence of SK & F 64139, a phenylethanolamine-N-methyltransferase inhibitor, on centrally mediated cardiovascular effects of alpha-methyldopa and clonidine. Gerold M; Haeusler G Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):276-81. PubMed ID: 6132343 [TBL] [Abstract][Full Text] [Related]
53. Effect of serum on adrenal PNMT activity. Matussek N; Deuringer L; Sardas-Trevorrow I J Neural Transm Gen Sect; 1992; 89(1-2):135-8. PubMed ID: 1418865 [TBL] [Abstract][Full Text] [Related]
54. Inhibitors of phenylethanolamine N-methyltransferase that are predicted to penetrate the blood-brain barrier: design, synthesis, and evaluation of 3-fluoromethyl-7-(N-substituted aminosulfonyl)-1,2,3,4-tetrahydroisoquinolines that possess low affinity toward the alpha2-adrenoceptor. Romero FA; Vodonick SM; Criscione KR; McLeish MJ; Grunewald GL J Med Chem; 2004 Aug; 47(18):4483-93. PubMed ID: 15317460 [TBL] [Abstract][Full Text] [Related]
55. Studies with a PNMT inhibitor. Dubb JW; Stote RM; Alexander F; Intoccia AP; Geczy M; Pendleton RG Clin Pharmacol Ther; 1979 Jun; 25(6):837-43. PubMed ID: 445951 [TBL] [Abstract][Full Text] [Related]
57. Evidence that alpha-methylepinephrine is an antihypertensive metabolite of alpha-methyldopa. Goldberg MR; Tung CS; Ring M; Oates JA; Gerkens JF; Robertson D Clin Exp Hypertens A; 1982; 4(4-5):595-604. PubMed ID: 7105433 [TBL] [Abstract][Full Text] [Related]